CYCC
Price
$2.70
Change
-$0.89 (-24.79%)
Updated
May 13, 04:59 PM (EDT)
Capitalization
744.34M
PRQR
Price
$1.54
Change
-$0.05 (-3.14%)
Updated
May 13, 04:59 PM (EDT)
Capitalization
167.29M
79 days until earnings call
Ad is loading...

CYCC vs PRQR

Header iconCYCC vs PRQR Comparison
Open Charts CYCC vs PRQRBanner chart's image
Cyclacel Pharmaceuticals
Price$2.70
Change-$0.89 (-24.79%)
Volume$2K
Capitalization744.34M
ProQR Therapeutics
Price$1.54
Change-$0.05 (-3.14%)
Volume$8.37K
Capitalization167.29M
CYCC vs PRQR Comparison Chart
Loading...
CYCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYCC vs. PRQR commentary
May 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYCC is a StrongBuy and PRQR is a Hold.

Ad is loading...
COMPARISON
Comparison
May 14, 2025
Stock price -- (CYCC: $3.59 vs. PRQR: $1.59)
Brand notoriety: CYCC and PRQR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYCC: 76% vs. PRQR: 53%
Market capitalization -- CYCC: $744.34M vs. PRQR: $167.29M
CYCC [@Biotechnology] is valued at $744.34M. PRQR’s [@Biotechnology] market capitalization is $167.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYCC’s FA Score shows that 1 FA rating(s) are green whilePRQR’s FA Score has 0 green FA rating(s).

  • CYCC’s FA Score: 1 green, 4 red.
  • PRQR’s FA Score: 0 green, 5 red.
According to our system of comparison, both CYCC and PRQR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYCC’s TA Score shows that 5 TA indicator(s) are bullish while PRQR’s TA Score has 7 bullish TA indicator(s).

  • CYCC’s TA Score: 5 bullish, 5 bearish.
  • PRQR’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, PRQR is a better buy in the short-term than CYCC.

Price Growth

CYCC (@Biotechnology) experienced а -24.93% price change this week, while PRQR (@Biotechnology) price change was -11.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.49%. For the same industry, the average monthly price growth was +10.87%, and the average quarterly price growth was -7.60%.

Reported Earning Dates

CYCC is expected to report earnings on Apr 02, 2025.

PRQR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+1.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYCC($744M) has a higher market cap than PRQR($167M). PRQR (-40.000) and CYCC (-40.326) have similar YTD gains . PRQR has more cash in the bank: 149M vs. CYCC (93K). CYCC has less debt than PRQR: CYCC (0) vs PRQR (17.2M).
CYCCPRQRCYCC / PRQR
Capitalization744M167M446%
EBITDAN/A-24.12M-
Gain YTD-40.326-40.000101%
P/E RatioN/AN/A-
RevenueN/A18.9M-
Total Cash93K149M0%
Total Debt017.2M-
FUNDAMENTALS RATINGS
CYCC vs PRQR: Fundamental Ratings
CYCC
PRQR
OUTLOOK RATING
1..100
3325
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
34
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
6459
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CYCC's Valuation (28) in the Biotechnology industry is in the same range as PRQR (34). This means that CYCC’s stock grew similarly to PRQR’s over the last 12 months.

CYCC's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PRQR (100). This means that CYCC’s stock grew similarly to PRQR’s over the last 12 months.

PRQR's SMR Rating (97) in the Biotechnology industry is in the same range as CYCC (100). This means that PRQR’s stock grew similarly to CYCC’s over the last 12 months.

PRQR's Price Growth Rating (59) in the Biotechnology industry is in the same range as CYCC (64). This means that PRQR’s stock grew similarly to CYCC’s over the last 12 months.

PRQR's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CYCC (100). This means that PRQR’s stock grew similarly to CYCC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CYCCPRQR
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 8 days ago
82%
Bullish Trend 12 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 8 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Ad is loading...
CYCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA318.3820.12
+6.75%
Tesla
AAPL210.7912.52
+6.31%
Apple
SPY582.9918.65
+3.30%
SPDR® S&P 500® ETF
GME28.050.51
+1.85%
GameStop Corp
BTC.X102812.950000-1293.406200
-1.24%
Bitcoin cryptocurrency

CYCC and

Correlation & Price change

A.I.dvisor tells us that CYCC and MTVA have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYCC and MTVA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYCC
1D Price
Change %
CYCC100%
-11.45%
MTVA - CYCC
26%
Poorly correlated
-3.88%
ANRO - CYCC
25%
Poorly correlated
+5.41%
HOWL - CYCC
24%
Poorly correlated
+25.03%
ONPPF - CYCC
23%
Poorly correlated
N/A
PRQR - CYCC
22%
Poorly correlated
-1.24%
More

PRQR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRQR has been loosely correlated with KRRO. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if PRQR jumps, then KRRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRQR
1D Price
Change %
PRQR100%
-1.24%
KRRO - PRQR
61%
Loosely correlated
+2.70%
WVE - PRQR
59%
Loosely correlated
+0.23%
ATNF - PRQR
55%
Loosely correlated
+0.92%
PHMMF - PRQR
36%
Loosely correlated
-8.25%
RCKT - PRQR
35%
Loosely correlated
+0.14%
More